Researchers in the United Kingdom recently completed an updated audit of the prostate safety data from the UK Androgen Study (UKAS). This was a long-term multicenter investigation into the treatment of age-related testosterone deficiency (hypogonadism) in men. The data was taken from a total of 1,365 men under treatment, with a mean age of 55 […]

The potential role of the primary male androgen testosterone in prostate cancer is controversial. Many prostate tumors are known to be androgen responsive, and thus grow under the stimulation of male sex hormones. Whether or not these same hormones play a role in cancer initiation in the first place has been the subject of much […]